Stimulation of GITR on effector CD8+ T cells results in high‐avidity T‐cell responses to tumor‐specific antigens, thereby inducing potent antitumor immunity in the absence of autoimmunity [8]. The gene discussed is CD8A; the disease is neoplasm.